Technology News and Research

RSS

Medical breakthrough: Scientists grow functioning human intestinal tissue from stem cells

Emerging Healthcare Solutions was encouraged by the latest breakthrough in stem cell research this week when scientists at Cincinnati Children's Hospital Medical Center announced that they've grown functioning human intestinal tissue from stem cells for the first time.

20 Dec 2010

Arthrosurface conducts first knee procedure based on HemiCAP platform technology

Arthrosurface, Inc., the developer of less-invasive joint resurfacing systems, announced that it has performed its first biological knee procedure based on the company's proven HemiCAP® platform technology.

19 Dec 2010

InspireMD presents long-term data of MGuard stent technology at the ICI

InspireMD, developer of the novel MGuard(TM), a combination of a coronary stent merged with an embolic protection specifically designed for Acute MI (AMI) patients, received significant exposure at the ICI, Innovations in Interventional Cardiology, meeting this week in Tel-Aviv. InspireMD presented long-term data, including two years of clinical follow-up, to support the Company's MGuard stent technology.

17 Dec 2010

Bio-IS and HSS sign 5-year partnership to deliver Bio-Intervention Disinfection Service to hospitals

Bio-Intervention Specialists (Bio-IS) and HSS Inc. (HSS) announced today that their companies have signed a five-year partnership to deliver the Bio-Intervention Disinfection Service to hospitals across the United States.

17 Dec 2010

Best Buy announces national rollout of health, fitness products at 600 Best Buy stores

Today Best Buy announces the national rollout of health and fitness products at 600 Best Buy stores across the country and online at Bestbuy.com. The selection aims to satisfy consumers' health and fitness needs through an array of traditional and new connected offerings for holiday gifting and just in time for New Year health and fitness resolutions.

17 Dec 2010

FFR-guided percutaneous coronary intervention provides cost-saving benefits

St. Jude Medical, Inc., a global medical device company, today announced the publication of results from an economic evaluation of the landmark FAME (Fractional Flow Reserve (FFR) vs. Angiography in Multivessel Evaluation) trial, which confirmed FFR-guided percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease improves patient outcomes and offers cost-saving benefits to the U.S. healthcare system.

17 Dec 2010

Possible stem cell cure for AIDS

An explosion of stem cell breakthroughs, including a possible cure for AIDS, is reshaping the possibilities for curing deadly and debilitating diseases around the globe, says Emerging Healthcare Solutions President and CEO Cindy Morrissey.

17 Dec 2010

Elsevier Foundation's new library grants focus on telemedicine, HIV/AIDS videos and Egyptian cancer database

The Elsevier Foundation has announced the 2010 recipients of grants under its Innovative Libraries in Developing Countries program, committing over $300,000 to support the work of libraries in developing countries. The 2010 grant recipients were selected from 260 proposals worldwide for their innovation and potential for impact in the developing world. The Innovative Libraries program supports capacity-building projects in the science, technology and medicine library training, education, infrastructure, digitization and the preservation of information.

17 Dec 2010

Diagenic, Pfizer enter collaboration to identify biomarkers in early stages of Alzheimer's disease

DiaGenic ASA and Pfizer Inc today signed an agreement for explorative R&D collaboration to identify biomarkers in early stages of Alzheimer's disease (AD) using DiaGenic's patented gene expression technology and its blood samples from ongoing clinical studies.

17 Dec 2010

Electronic medical records appear to have varying effects on primary care physicians: UC Davis study

The introduction of electronic medical records in hospitals and clinics—dubbed the "silver bullet" of health care reform—appears to have varying effects on different types of primary care physicians, a UC Davis study has found.

17 Dec 2010

U.N. says it will investigate source of Haitian cholera epidemic as death toll rises

The U.N. is looking into establishing an independent commission to identify the source of Haiti's cholera epidemic, Alain Le Roy, the U.N. under-secretary-general for peacekeeping operations, said on Wednesday, the Associated Press/Washington Post reports. "We are urging and we are calling for what we could call an international panel," Le Roy said at a news conference at the U.N. headquarters in New York. "We are in discussions with (the U.N. World Health Organization) to find the best experts to be in a panel to be completely independent," he added.

17 Dec 2010

Celator granted U.S. Patent covering CombiPlex technology platform

Celator Pharmaceuticals today announced the United States Patent and Trademark Office issued U.S Patent No. 7,850,990. This patent adds to the intellectual property surrounding Celator's innovative technology platforms and products.

17 Dec 2010

Researchers contribute important expertise to new landmark study of medulloblastoma

Pediatric cancer researchers at The Children's Hospital of Philadelphia contributed important expertise to a new landmark study of medulloblastoma, a type of brain tumor typically found in children. The large multicenter study defines the genetic landscape of this cancer, and holds intriguing clues to gene changes on signaling pathways that may become fruitful targets for future therapies.

17 Dec 2010

BioMimetic granted Canadian notice of patent allowance covering rhPDGF-BB platform technology formulations

BioMimetic Therapeutics, Inc. announced today the Canadian Intellectual Property Office (CIPO) has allowed patent application No. 2,583,823 titled "Platelet Derived Growth Factor (PDGF) Compositions and Methods of Use Thereof". The new patent will remain in force until October 2025, during which time it will prohibit the marketing of similar or generic versions of the Company's Augment™ orthopedic product line and certain other rhPDGF-BB product formulations.

17 Dec 2010

GE Healthcare announces global partnership with Embrace to distribute low-cost infant warmer

GE Healthcare today announced a global partnership with Embrace to distribute a low-cost infant warmer that looks like a small sleeping bag and can help keep an infant warm for hours. This product will be distributed in India initially to improve rural infant care as an alternative to more expensive warmers.

17 Dec 2010

Cancer Treatment Centers of America deploys Intel's personal health system solution

Cancer Treatment Centers of America (CTCA) is deploying the Intel® Health Guide - a next-generation personal health system solution that allows physicians and clinicians to proactively monitor their patients' care at home - as part of its commitment to provide patients with the information and resources they need to make educated decisions about their cancer care.

17 Dec 2010

City Tech Nursing Professor provides community-based care plan to study difference in health outcomes

Patients with diabetes who follow a self-care regimen generally have success in controlling their disease. But what about patients whose other health conditions, such as cognitive impairment and/or depression, create barriers to effective treatment?

17 Dec 2010

Pediatric cancer researchers study medulloblastoma for new treatment

Pediatric cancer researchers at The Children's Hospital of Philadelphia contributed important expertise to a new landmark study of medulloblastoma, a type of brain tumor typically found in children.

17 Dec 2010

Genetic biomarker linked to increased risk for breast cancer found in 'junk' DNA

A new genetic biomarker that indicates an increased risk for developing breast cancer can be found in an individual's "junk" (non-coding) DNA, according to a new study featuring work from researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and their colleagues.

17 Dec 2010

AFFiRiS AG receives 475,000 MJFF grant for Parkinson vaccine development

With a grant of USD 475,000, the Michael J. Fox Foundation is funding preclinical development of a vaccine against Parkinson's disease by AFFiRiS AG. The vaccine, known as PD01, targets the protein alpha-synuclein and might offer for the first time a possibility for a treatment that can slow or stop the progression of Parkinson's disease.

17 Dec 2010

Technology News and Research

Medical breakthrough: Scientists grow functioning human intestinal tissue from stem cells

Arthrosurface conducts first knee procedure based on HemiCAP platform technology

InspireMD presents long-term data of MGuard stent technology at the ICI

Bio-IS and HSS sign 5-year partnership to deliver Bio-Intervention Disinfection Service to hospitals

Best Buy announces national rollout of health, fitness products at 600 Best Buy stores

FFR-guided percutaneous coronary intervention provides cost-saving benefits

Possible stem cell cure for AIDS

Elsevier Foundation's new library grants focus on telemedicine, HIV/AIDS videos and Egyptian cancer database

Diagenic, Pfizer enter collaboration to identify biomarkers in early stages of Alzheimer's disease

Electronic medical records appear to have varying effects on primary care physicians: UC Davis study

U.N. says it will investigate source of Haitian cholera epidemic as death toll rises

Celator granted U.S. Patent covering CombiPlex technology platform

Researchers contribute important expertise to new landmark study of medulloblastoma

BioMimetic granted Canadian notice of patent allowance covering rhPDGF-BB platform technology formulations

GE Healthcare announces global partnership with Embrace to distribute low-cost infant warmer

Cancer Treatment Centers of America deploys Intel's personal health system solution

City Tech Nursing Professor provides community-based care plan to study difference in health outcomes

Pediatric cancer researchers study medulloblastoma for new treatment

Genetic biomarker linked to increased risk for breast cancer found in 'junk' DNA

AFFiRiS AG receives 475,000 MJFF grant for Parkinson vaccine development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News